Register entry

Ishihara Sangyo Kaisha, Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
Japan
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Ishihara Sangyo Kaisha, Ltd.1, Ishiharacho, Yokkaichi, Mie 510-0842, Japan (JPN)Active ingredient (API) manufacture3002807309706277050
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-cevimelinepowder64642-011BULK INGREDIENT
Neighbours

Registered in the same town

1
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Ishihara Sangyo Kaisha, Ltd. FDA approved?
Ishihara Sangyo Kaisha, Ltd. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Ishihara Sangyo Kaisha, Ltd.'s drugs manufactured?
The FDA register lists Yokkaichi. Registered operations: active ingredient (API) manufacture.
What drugs does Ishihara Sangyo Kaisha, Ltd. make?
1 product is listed under Ishihara Sangyo Kaisha, Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.